Bayer faces pivotal test of $7.25 billion Roundup settlement in Missouri court

•1mo ago

Bayer faces pivotal test of $7.25 billion Roundup settlement in Missouri court

Tap title to read story

0:00 / 1:05

Bayers Monsanto unit appeared in a Missouri state court to seek approval for a proposed 7.25 billion dollar settlement resolving tens of thousands of United States lawsuits alleging that Roundup weedkiller causes cancer. Judge Timothy Boyer evaluated the framework during a St. Louis hearing, listening to objections from plaintiffs lawyers who argued clients deserved better terms alongside proponents supporting guaranteed compensation. The litigation has weighed heavily on Bayer since its 2018 acquisition of Monsanto, impacting share prices and creating ongoing corporate liabilities. Chief Executive Bill Anderson has prioritized resolving these claims under a broader turnaround strategy. While the settlement offers payouts ranging from 10000 dollars to 165000 dollars for non-Hodgkin lymphoma diagnoses, the court did not issue an immediate ruling. Bayer continues to deny liability, citing decades of safety studies and Environmental Protection Agency findings indicating glyphosate does not cause cancer under normal exposure conditions.

Published 2026-09-13 16:52:44 UTC · Published by JQJO

Prepared by Ayesha A. · AI assisted

More context

Timeline

2015-03 — World Health Organization declared glyphosate a probable carcinogen.
2018-06 — Bayer acquired Monsanto for sixty three billion dollars.
2020-06 — Bayer announced a major settlement worth ten billion dollars.
2026-02 — Bayer announced a proposed seven point twenty five billion settlement.
On September 11 2026 Reuters reported on the upcoming court hearing.
On September 14 2026 Judge Boyer examined settlement objections in Missouri court.
On September 13 2026 No newer material development was located during the final freshness search.
Judicial review of class action objections will continue across upcoming months.
Legal battles regarding glyphosate cancer claims will persist into coming years.
2026-12 — Regulatory assessments by environmental agencies will conclude near late 2026.

Why it matters

Immediate US impact: Corporate liabilities and stock values face significant ongoing market shifts. Possible long-term US impact: Settlement approval could permanently stabilize long-term agricultural chemical market risks. Most affected groups: Monsanto agricultural workers, cancer patients, investors, and legal firms. Reader priority: Monitor court filings and legal analyses across financial news networks.

Coverage notes

Left: Emphasizes corporate accountability and adequacy of payouts for victims. Center: Reports neutral facts on judicial review and corporate financial impacts. Right: Highlights economic stability, turnaround progress, and regulatory science consistency.